Literature DB >> 16399153

Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data.

David A Leon1, Jim McCambridge.   

Abstract

BACKGROUND: Rates of mortality due to cirrhosis of the liver are an important indicator of population levels of alcohol harm. Total recorded alcohol consumption in Britain doubled between 1960 and 2002, giving rise to a need to examine and assess cirrhosis mortality trends.
METHODS: Mortality rates were calculated for all ages and for specific age-groups (15-44 years and 45-64 years) for cirrhosis of the liver. Rates were directly age-standardised to the European standard population and compared with rates from 12 western European countries for the period 1955-2001.
FINDINGS: Cirrhosis mortality rates increased steeply in Britain during the 1990s. Between the periods 1987-1991, and 1997-2001, cirrhosis mortality in men in Scotland more than doubled (104% increase) and in England and Wales rose by over two-thirds (69%). Mortality in women increased by almost half (46% in Scotland and 44% in England and Wales). These relative increases are the steepest in western Europe, and contrast with the declines apparent in most other countries examined, particularly those of southern Europe. Cirrhosis mortality rates in Scotland are now one of the highest in western Europe, in 2002 being 45.2 per 100,000 in men and 19.9 in women.
INTERPRETATION: Current alcohol policies in Britain should be assessed by the extent to which they can successfully halt the adverse trends in liver cirrhosis mortality. The situation in Scotland warrants particular attention.

Entities:  

Mesh:

Year:  2006        PMID: 16399153     DOI: 10.1016/S0140-6736(06)67924-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  106 in total

1.  Studies on avian erythrocyte metabolism--I. Procedure for separation and quantitation of the major phosphorylated metabolic intermediates by anion exchange chromatography.

Authors:  R E Isaacks; D R Harkness; G A Froeman; S A Sussman
Journal:  Comp Biochem Physiol A Comp Physiol       Date:  1976-01

2.  A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance.

Authors:  Trevor N Johnson; Koen Boussery; Karen Rowland-Yeo; Geoffrey T Tucker; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2010-03       Impact factor: 6.447

3.  Heme oxygenase system in hepatic ischemia-reperfusion injury.

Authors:  James A Richards; Stephen J Wigmore; Luke R Devey
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

4.  Hazardous drinking and the NHS: the costs of pessimism and the benefits of optimism.

Authors:  Jim McCambridge; John Strang; Chris C Butler; Francis Keaney; Peter Anderson
Journal:  Br J Gen Pract       Date:  2006-04       Impact factor: 5.386

Review 5.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

6.  An alcoholic patient who continues to drink: endoscopic treatment is preferred.

Authors:  Mark Hudson
Journal:  BMJ       Date:  2006-02-18

Review 7.  Diagnosis and management of alcohol use disorders.

Authors:  Andrew J R Parker; E Jane Marshall; David M Ball
Journal:  BMJ       Date:  2008-03-01

8.  Wealth and health. Will the global credit crunch cause a health crunch in the most affected countries?

Authors:  Philip Hunter
Journal:  EMBO Rep       Date:  2009-08       Impact factor: 8.807

9.  Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology.

Authors:  Sandip Hindocha; Duncan Angus McGrouther; Ardeshir Bayat
Journal:  Hand (N Y)       Date:  2009-01-15

Review 10.  Immune dysfunction in acute alcoholic hepatitis.

Authors:  Ashwin D Dhanda; Peter L Collins
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.